Dapagliflozin 10mg & Vildagliptin 100mg Bilayered Sustained Release Tablet is a combination antidiabetic medication designed for the effective management of type 2 diabetes mellitus. Dapagliflozin belongs to the SGLT2 inhibitor class, which helps lower blood glucose by promoting renal glucose excretion. Vildagliptin is a DPP-4 inhibitor that enhances the incretin system, improving insulin secretion and reducing glucagon levels in a glucose-dependent manner. The bilayered sustained-release formulation ensures gradual release of active ingredients, providing prolonged glycemic control and improved patient compliance. This combination is particularly beneficial for patients inadequately controlled with diet and exercise alone or those who require a complementary mechanism to achieve target blood glucose levels. Regular monitoring of blood glucose, adherence to diet, and lifestyle modifications enhance the therapeutic effectiveness of this medication.
